Allergan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.11.14	Actavis To Buy Allergan In $66 Bln Deal - Quick Facts (RTTNews)
17.11.14	Reports: Actavis Nears Deal To Acquire Allergan (RTTNews)
12.11.14	Actavis Reportedly In Talks To Buy Allergan For At Least $60 Bln (RTTNews)
12.11.14	Allergan Board Reports Approval Of Amendments To Company's Bylaws - Quick Facts (RTTNews)
05.11.14	Court Says Valeant, Pershing Square May Vote In Allergan Dec.18 Stockholder Meet (RTTNews)
04.11.14	Allergan Says Approached By Another Party Regarding A Potential Transaction (RTTNews)
27.10.14	Allergan : Valeant's Letter Simply Tactic To Distract Investors From Q3 Results (RTTNews)
27.10.14	Allergan Q3 Results Top View; Valeant Prepared To Raise Offer For Botox Maker (RTTNews)
27.10.14	Allergan Q3 Profit Beats Estimates - Quick Facts (RTTNews)
27.10.14	Valeant :prepared To Improve For Allergan And Provide Value Of At Least $200/shr (RTTNews)
20.10.14	Valeant Pharma Turns To Profit In Q3, Lifts 2014 Earnings Outlook (RTTNews)
09.10.14	Allergan Lifts Q3, 2014 Earnings Outlook (RTTNews)
09.10.14	Allergan Lifts Q3, 2014 Adj. EPS View - Quick Facts (RTTNews)
08.10.14	Valeant To Raise Allergan Bid By $15 A Share: Reports (RTTNews)
03.10.14	Salix Pharma Ends Cosmo Deal; Stock Up On Reports Of Talks For Sale To Actavis (RTTNews)
02.10.14	Proxy Firm ISS Urges Allergan For Shareholder Vote (RTTNews)
01.10.14	Ackman's Pershing Square Raises More Than $3 Bln In Amsterdam IPO (RTTNews)
29.09.14	Allergan Says Its View On Valeant's Offer Remains Unchanged (RTTNews)
29.09.14	Allergan Says FDA Approves Revised Indication For OZURDEX (RTTNews)
29.09.14	Allergan Says Its Conclusion On Valeant's Offer Remains Unchanged - Quick Facts (RTTNews)
26.09.14	T.Rowe Urges Allergan To Seek Shareholders Vote On Acquisitions - Update (RTTNews)
25.09.14	Allergan: "can Create More Value Than Valeant's Offer" (RTTNews)
24.09.14	Valeant Pharma Sees Strong Q3 Results, Urges Allergan To Hold Merger Talks (RTTNews)
24.09.14	Valeant Sees Q3 Results To Beat Consensus On Revenue; Sends Letter To Allergan (RTTNews)
23.09.14	Ackman Threatens To Sue Allergan Over Salix Deal: Reports (RTTNews)
23.09.14	Reports: Allergan In Advanced Talks To Acquire Salix Pharmaceuticals (RTTNews)
16.09.14	Pershing Square, Valeant Pharma Settle Litigation With Allergan - Quick Facts (RTTNews)
15.09.14	Ackman's Pershing Square Plans To Raise $2 Bln Through IPO In Amsterdam: Reports (RTTNews)
12.09.14	Pershing Square Says More Allergan Shareholders Support Call For Special Meeting (RTTNews)
12.09.14	Pershing Square Submits Addl. Special Meeting Requests - Quick Facts (RTTNews)
12.09.14	Allergan Comments On Pershing Square's Delivery Of Additional Requests (RTTNews)
05.09.14	Allergan Approves Requests OF Stockholders For Special Meeting - Quick Facts (RTTNews)
27.08.14	Valeant, Pershing Square Allowed Fast-Track Trial Over Allergan Special Meeting (RTTNews)
23.08.14	Pershing Square Submits Written Requests For Allergan Special Meeting (RTTNews)
19.08.14	Allergan Reportedly Seeks Salix To Thwart Valeant Bid- Update (RTTNews)
18.08.14	Allergan Names Jim Hindman CFO, Effective Immediately - Quick Facts (RTTNews)
15.08.14	Valeant Extends Exchange Offer To Acquire Allergan (RTTNews)
05.08.14	Allergan Says Valeant Disclosures Continue To Be Insufficient And Inconsistent (RTTNews)
01.08.14	Allergan Sues Valeant, Ackman Over Insider Trading - Update (RTTNews)
01.08.14	Allergan Files Lawsuit Against Valeant Pharmaceuticals (RTTNews)
25.07.14	Allergan's OZURDEX Gets European Positive Opinion For Treating DME (RTTNews)
11.07.14	Allergan Brushes Aside Pershing Square's Proxy Solicitation (RTTNews)
07.07.14	Ackman's Pershing Square Proposes Six Nominees For Allergan Board - Update (RTTNews)
07.07.14	Pershing Square Proposes 6 Directors For Allergan Board (RTTNews)
30.06.14	Allergan Gets FDA Approval For Ozurdex, Announces R&D Pipeline Update (RTTNews)
25.06.14	Valeant Submits Preliminary Proxy Statement For Special Meeting Of Shareholders (RTTNews)
24.06.14	ASPX Awaits Results, BZYR Creating Buzz, CGIX Opens Wallet, GNCA Hits A High (RTTNews)
23.06.14	Allergan Urges Shareholders Not To Tender Shares To Valeant Exchange Offer (RTTNews)
23.06.14	Allergan Rejects Valeant's Tender Offer - Quick Facts (RTTNews)
18.06.14	Valeant's Tender Offer For Allergan Begins (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

26.11.24		Dow Jones aktuell: Dow Jones zum Handelsende in Grün
26.11.24		Börse New York: Dow Jones wenig verändert
26.11.24		Verluste in New York: Dow Jones legt den Rückwärtsgang ein
26.11.24		Börse Zürich: SMI letztendlich in Rot
26.11.24		Dow Jones 30 Industrial-Papier Merck-Aktie: Wäre eine Merck-Investition von vor einem Jahr lukrativ gewesen?
26.11.24		S&P 500-Wert Pfizer-Aktie: So viel Verlust wäre bei einem Investment in Pfizer von vor einem Jahr angefallen
26.11.24		Schwacher Handel in New York: Dow Jones zum Start mit Abgaben

26.11.24

Dow Jones aktuell: Dow Jones zum Handelsende in Grün

26.11.24

Börse New York: Dow Jones wenig verändert

26.11.24

Verluste in New York: Dow Jones legt den Rückwärtsgang ein

26.11.24

Börse Zürich: SMI letztendlich in Rot

26.11.24

Dow Jones 30 Industrial-Papier Merck-Aktie: Wäre eine Merck-Investition von vor einem Jahr lukrativ gewesen?

26.11.24

S&P 500-Wert Pfizer-Aktie: So viel Verlust wäre bei einem Investment in Pfizer von vor einem Jahr angefallen